cancer research

A new study shows how loss of parts of the Y chromosome, a common age-related change in men's cells, can promote cancer growth. Researchers report the missing pieces help tumours evade immune defences, offering a possible explanation for why some cancers in men are more aggressive and opening paths to new treatments.

Researchers report observing how an aggressive brain cancer physically remodels brain tissue as it grows, offering a live view of tumor progression. The findings shed light on how deadly brain tumors invade and distort surrounding structures, which could inform future treatment approaches. The work is drawing attention for its striking visualization of the disease's effects on the brain.

Coverage is circulating of the second part of a highlights roundup from the World Cancer Congress 2026, summarising key presentations and developments shared at the global oncology gathering. The roundup is aimed at cancer professionals and researchers following the congress remotely, distilling sessions into digestible takeaways. Interest centres on what new research, treatment approaches and policy discussions were featured at this year's event.

Researchers led by Dr. Jona Kayser at MPZPM report that physical processes within dense cell populations strongly influence the optimal timing of treatment cycles in cancer and antibiotic therapy. Treatment resistance is a central obstacle in both fields, and the findings suggest that scheduling therapies around these dynamics could improve outcomes. The work, associated with the Max Planck Institute for the Science of Light, points to a greater role for biophysics in designing treatment schedules.

A new report outlines how biological research is changing the way breast cancer is diagnosed and treated. Understanding tumour biology is increasingly guiding treatment choices, moving care away from one-size-fits-all approaches toward therapies matched to the specific characteristics of each patient's cancer. The piece has drawn attention from clinicians and patient advocates following shifts in treatment standards.

Researchers publishing in Communications Biology report that deletions and regulatory disruption of the Y chromosome recur across cancers, suggesting loss of this chromosome may play a functional role in tumour development rather than being a harmless byproduct. The findings add to growing interest in how sex chromosome instability shapes cancer risk and progression in men.

The World Cancer Congress 2026 is drawing attention with a roundup of its key moments and announcements. Coverage so far focuses on highlights from the global gathering of cancer researchers, clinicians and advocates, though specific findings or policy outcomes have not yet been detailed. Interest is expected to grow as sessions conclude and results are shared.

The Trump administration has committed more than $5 billion to a program called the Genesis Mission, aimed at advancing cancer research, semiconductor development, and quantum computing. The initiative signals a major federal investment in strategic technologies, combining health science goals with industrial policy on chips and next-generation computing capabilities.

Researchers have highlighted three previously overlooked RNA molecules as potential new markers for colorectal cancer. The findings suggest these molecules could help detect the disease earlier and guide treatment choices, offering a possible addition to existing screening and diagnostic tools. Colorectal cancer remains one of the most common cancers worldwide, so any lead on earlier detection is drawing scientific and media attention.

New figures from the European Commission show that 5% of Europeans consumed alcohol every day in 2025. The statistic highlights that despite overall declines in drinking across much of the continent, a small but notable share of the population still drinks daily, a pattern linked in public health research to higher risks of liver disease, cancer and other harms. Health advocates are likely to use the data in ongoing debates over alcohol pricing, advertising and labelling rules across EU member states.

Researchers describe a 'proliferative pause' — a period when cancer cells spreading to the brain stop dividing before reactivating — and suggest this dormant phase could be a critical treatment window to stop brain metastases before they take hold. Targeting cells during this pause may prevent lethal secondary brain tumours in cancers prone to spreading there.

Volunteers and advocates with the American Cancer Society's Cancer Action Network visited Capitol Hill to meet with members of Congress, urging support for cancer research funding and patient-focused legislation. The advocacy day brings grassroots concerns about prevention, treatment access, and federal research investment directly to lawmakers, and is part of the organization's ongoing effort to keep cancer policy on the national legislative agenda.

Researchers report that biological features of prostate tumours can help determine which patients are most likely to benefit from hormone therapy. By profiling tumour biology, doctors may be able to better target treatment and avoid giving hormone therapy to those unlikely to respond, a step toward more personalised prostate cancer care.

Dr. Ilyas Sahin has drawn attention to a new scientific study on colorectal cancer liver metastasis, one of the most common and difficult sites of colorectal cancer spread. The findings are being shared among oncology watchers interested in how the disease progresses and what new treatment approaches might follow.

Researchers have documented recurrent deletions and regulatory disruption of the Y chromosome across cancer types, according to a study published in Nature. The work suggests loss or alteration of Y chromosome genetic material may play a functional role in tumour development rather than being incidental, opening questions about how such changes influence cancer biology and potential sex-based differences in disease.

Iowa State University researchers are working on ways to reduce firefighters' elevated risk of cancer, which has been linked to exposure to toxic chemicals and smoke on the job. The Gazette reports on the effort, which comes as firefighting is increasingly recognised as a hazardous occupation with higher cancer rates than the general population.

UT Health San Antonio is working to find a cure for liver cancer, a disease affecting communities across South Texas at elevated rates. The health institution's research efforts were highlighted in local coverage, drawing attention to the region's particular vulnerability and the push for better treatments.